BUZZ-IntelliPharmaCeutics International Inc: Positive data on painkiller

Thu Jan 14, 2016 10:32am EST
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Generic drug maker's U.S.-listed shares up 13.7 pct at $2.41

** Company said its experimental painkiller Rexista Oxycodone XR had similar effect on patients as Purdue Pharma's existing drug Oxycontin, both of which share same active ingredient

** U.S. Food and Drug Administration said in May that company would not be required to conduct late-stage study for drug if it showed bioequivalence to Oxycontin

** IntelliPharmaCeutics said it expected to file marketing application for drug with FDA within next 6 months

** Stock fell 10 pct in 2015